Organogenesis Holdings Inc. (ORGO) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Organogenesis Holdings Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.058 Please stand by. Welcome, ladies and gentlemen, to the fourth quarter and full year 00:00:05.058 -- 00:00:06.761 2025 00:00:06.761 -- 00:00:11.307 earnings conference call for OrganiGenesis Holding Inc. 00:00:11.307 -- 00:00:15.313 At this time, all participants have been placed in listen-only mode. 00:00:15.313 -- 00:00:20.360 Please note that this conference call is being recorded and that the recording will 00:00:20.360 -- 00:00:24.145 be available on the company's website for replay shortly. 00:00:24.145 -- 00:00:29.640 Before we begin, I would like to remind everyone that our remarks today may contain forward-looking 00:00:29.640 -- 00:00:34.387 statements that are based on the current expectations of management and involve inherent 00:00:34.387 -- 00:00:39.295 risk and uncertainties that it could cause actual results to differ materially from those 00:00:39.295 -- 00:00:44.383 indicated, including the risk and uncertainties described in the company's filings with 00:00:44.383 -- 00:00:49.431 the Securities and Exchange Commission, including Item 1A, Risk Factors, of 00:00:49.431 -- 00:00:55.634 the company's most recent annual report and its subsequently filed quarterly report. 00:00:55.634 -- 00:01:00.699 You are cautioned not to place undue reliance upon any forward-looking statements which 00:01:00.699 -- 00:01:06.224 speak only as of the date made. Although it may voluntarily 00:01:06.224 -- 00:01:10.428 do so from time to time, the company undertakes no commitment to update or revise the 00:01:10.428 -- 00:01:15.173 forward-looking statements, whether as a result of new information, further events, or 00:01:15.173 -- 00:01:19.837 otherwise, except as required by applicable security laws. 00:01:19.837 -- 00:01:24.969 This...